On September 22, Gan Shaoning, deputy director of China's State Intellectual Property Office, met with Wang Lei, global executive vice president of AstraZeneca Pharmaceutical Co., Ltd., and his party in Beijing. The two sides exchanged views on the progress of China's intellectual property work and the protection of intellectual property in the pharmaceutical field. Gan Shaoning said that the Chinese government has always attached great importance to intellectual property rights, and has gradually established an intellectual property laws and regulations system and an efficient intellectual property work system with complete protection categories, in line with international standards and in line with China's national conditions. China will continue to actively create a fair and transparent environment for innovation and business, and adhere to equal treatment and protection of intellectual property rights of domestic and foreign enterprises. Wang Lei appreciated the work done by the Chinese government in intellectual property protection and hoped to continue to strengthen exchanges with the State Intellectual Property Office of China. (Xiong Huaping, intern reporter of intellectual property newspaper / Zeng Jia, reporter / photo)